Related Experiment Video

Updated: Jul 3, 2026

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/- mice

Gerald F Späth1, Mary Ann McDowell, Stephen M Beverley

  • 1Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Experimental Parasitology
|August 7, 2008
PubMed

Insights

Leishmania parasites infect macrophages, but their survival does not depend on the host cell phosphatases SHP-1 or CD45. This finding challenges previous assumptions about Leishmania immune evasion strategies.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Leishmania parasites evade host immunity by disrupting macrophage signaling.
  • Macrophage activation inhibition is linked to SHP-1 phosphatase activity.
  • Previous studies suggested SHP-1 is crucial for Leishmania survival.

Purpose of the Study:

  • To investigate the role of SHP-1 and CD45 phosphatases in Leishmania major intracellular survival.
  • To determine if Leishmania evasion relies on these specific host cell phosphatases.

Main Methods:

  • Infection of SHP-1 deficient (me(v)) mice and macrophages.
  • Infection of CD45 null mutant mice and macrophages.
  • Analysis of Leishmania major intracellular survival in these models.

Main Results:

  • Leishmania major intracellular survival was not significantly impaired in SHP-1 deficient macrophages.
  • Leishmania major intracellular survival was not significantly impaired in CD45 null mutant macrophages.
  • These findings indicate Leishmania major does not generally depend on SHP-1 or CD45 for survival.

Conclusions:

  • Intracellular survival of Leishmania major is not generally dependent on SHP-1 or CD45.
  • This challenges the established model of Leishmania immune evasion.
  • Further research is needed to elucidate alternative mechanisms of Leishmania immune evasion.

More Related Videos

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...